Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion type Assertion NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_head.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion description "[Two models of leukemia were used, one genetic (conditional alpha4 ablation of BCR-ABL1 [p210(+)] leukemia) and one pharmacological (anti-functional alpha4 antibody treatment of primary ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_provenance.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion evidence source_evidence_literature NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_provenance.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion SIO_000772 23319569 NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_provenance.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion wasDerivedFrom befree-2016 NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_provenance.
- NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_assertion wasGeneratedBy ECO_0000203 NP1043900.RAGtpDRYT5YFTRM9YXf8Ppmh08M0R-ESjWfTJ-aszOfkw130_provenance.